| 1 | 
                
                    Cemdisiran
                
             | [1]  Cemdisiran Cemdisiran | - | - | - | [4]  11 11, 62, 66, 109 💬
 | 
| 2 | 
                
                    Crovalimab
                
             | [1]  CROVALIMAB CROVALIMAB | [1]  Crovalimab 
                
                    Crovalimab
                
             💬
 | [1]  C5 C5 💬
 | [11]  Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2]  62 62, 109 💬
 | 
| 3 | 
                
                    Eculizumab
                
             | [2]  ECULIZUMAB ECULIZUMAB; SOLIRIS | [1]  Eculizumab 
                
                    Eculizumab
                
             💬
 | [1]  C5 C5 💬
 | [11]  Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7]  11 11, 13, 14, 61, 62, 109, 222 💬
 | 
| 4 | 
                
                    Iptacopan
                
             | [1]  Iptacopan Iptacopan | [1]  Iptacopan 
                
                    Iptacopan
                
             💬
 | [1]  CFB CFB 💬
 | [3]  Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [5]  61 61, 62, 66, 109, 222 💬
 | 
| 5 | 
                
                    Narsoplimab
                
             | [2]  MASP-2 antibody MASP-2 antibody; Narsoplimab | [1]  Narsoplimab 
                
                    Narsoplimab
                
             💬
 | [1]  MASP2 MASP2 💬
 | [3]  Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [4]  64 64, 66, 109, 222 💬
 | 
| 6 | 
                
                    Nomacopan
                
             | [2]  COVERSIN COVERSIN; NOMACOPAN | [1]  Nomacopan 
                
                    Nomacopan
                
             💬
 | [1]  C5 C5 💬
 | [11]  Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3]  62 62, 109, 162 💬
 | 
| 7 | 
                
                    Ravulizumab
                
             | [2]  Ravulizumab Ravulizumab; ULTOMIRIS | [1]  Ravulizumab 
                
                    Ravulizumab
                
             💬
 | [1]  C5 C5 💬
 | [11]  Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7]  2 2, 11, 13, 50, 62, 66, 109 💬
 |